Glimepiride & Metformine Hydrochloride (Sustained Release) Tablets | Brand – Minmek-G1 | Manufacturer – CARDMEK | Pack of 1×10 Tab

Description:Minmek-G1 combines Metformin HCL (Sustained Release) 500mg and Glimepiride 1mg for effective management of type 2 diabetes. This formulation ensures consistent blood sugar control through a dual mechanism: improving insulin sensitivity and stimulating insulin secretion.Key Benefits:Metformin HCL (SR): Provides steady glucose control by reducing liver glucose production and enhancing insulin sensitivityGlimepiride: Stimulates insulin release from the pancreasHelps maintain stable blood sugar levels throughout the dayReduces the risk of diabetes-related complicationsComposition:Metformin HCL (SR) 500mg: A sustained-release form that offers prolonged blood glucose regulationGlimepiride 1mg: Promotes insulin secretion to lower blood glucose levelsRecommended Usage:Take 1 tablet daily with food or as directed by your healthcare provider. Dosage may be adjusted based on individual blood sugar levels and response to treatment.